The Impact of Histological Variants of Urothelial Carcinoma on Clinical Outcomes Following Trimodality Bladder-sparing Chemoradiation

Eur Urol. 2017 Jul;72(1):61-63. doi: 10.1016/j.eururo.2017.01.045. Epub 2017 Feb 14.

Authors

Anne E Kiltie¹, Lisa Browning²

Affiliations

¹ CRUK/MRC Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, UK. Electronic address: [email protected].
² Department of Cellular Pathology, Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Oxford, UK.

PMID: 28214031
DOI: 10.1016/j.eururo.2017.01.045

No abstract available

Publication types

Editorial
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Carcinoma, Transitional Cell / surgery*
Chemoradiotherapy
Cystectomy
Humans
Urinary Bladder Neoplasms / surgery
Urinary Bladder*

Grants and funding